Nutex Health Inc.
NUTX
$44.66
-$1.84-3.96%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -42.23% | 91.30% | 90.92% | 89.22% | 92.70% |
| Total Depreciation and Amortization | 13.56% | 15.11% | 20.75% | 33.96% | 38.91% |
| Total Amortization of Deferred Charges | -37.13% | -28.16% | 43.92% | 26.07% | 6,270.97% |
| Total Other Non-Cash Items | 1,176.68% | -91.42% | -93.26% | -92.76% | -99.13% |
| Change in Net Operating Assets | -108.89% | -95.82% | -104.69% | -102.58% | -84.15% |
| Cash from Operations | 182.87% | 1,053.05% | -79.55% | -97.52% | -91.85% |
| Capital Expenditure | 55.66% | 38.77% | 43.81% | 35.10% | 92.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 105.36% | -- | -105.54% | -105.54% | -105.85% |
| Divestitures | 65.23% | 31.55% | 100.00% | 57.08% | 57.93% |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 66.76% | 26.78% | -464.48% | -159.14% | 82.38% |
| Total Debt Issued | 11.56% | -30.47% | 186.89% | 603.72% | -36.01% |
| Total Debt Repaid | 0.50% | -23.22% | -163.59% | -138.71% | -94.44% |
| Issuance of Common Stock | 1,587.88% | 1,177.51% | 70.90% | -93.23% | -96.55% |
| Repurchase of Common Stock | -12.84% | -12.84% | -12.84% | -12.84% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 82.08% | 82.08% | 90.13% | 94.38% | 96.51% |
| Other Financing Activities | 27.78% | 78.22% | 70.10% | 70.14% | 78.38% |
| Cash from Financing | 101.24% | 44.20% | 102.70% | 95.28% | 80.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 305.05% | 154.25% | -3.98% | -557.71% | -511.08% |
